How Myriad Genetics (MYGN) Strategized to Undermind Its New Genetic Testing Competitors
11/29/2016 7:10:28 AM
No company has had a more profound impact on inherited breast and ovarian cancer than Myriad Genetics. Its DNA test to identify women with a sharply increased chance of developing these cancers changed millions of lives: Many women who learned they had a cancer-causing mutation had their breasts and ovaries removed in an effort to dodge the genetic bullet.
comments powered by